Literature DB >> 12057139

Superior sulcus tumors.

C D Wright1, D J Mathisen.   

Abstract

Superior sulcus tumors (also known as Pancoast's tumors) are an unusual presentation of non-small cell lung cancer (NSCLC) that are often initially misdiagnosed. Accurate and thorough staging is necessary prior to treatment and typically includes magnetic resonance imaging if a surgical approach is being considered. Standard therapy has been induction radiation therapy followed by resection, which results in a 5-year survival of about 30%. Complete resection remains the key to long-term survival in localized NSCLC but is difficult to achieve with superior sulcus tumors due to early invasion of bone and to vascular and nervous structures at the apex of the chest. Complete resection has been enhanced by using an anterior trans-cervicomediastinal approach that facilitates resection of anterior-based tumors that invade the subclavian vessels. Recently, induction chemoradiotherapy has been reported to enhance complete resection rates and improve survival compared with historical controls and is likely to become the new standard treatment for localized superior sulcus tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12057139     DOI: 10.1007/s11864-001-0015-7

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  23 in total

1.  Modification of anterior approach to superior sulcus tumors.

Authors:  T Onuki; M Murasugi; M Mae; Y Sone; J Kei; S Nitta
Journal:  J Thorac Cardiovasc Surg       Date:  1998-10       Impact factor: 5.209

Review 2.  Superior pulmonary sulcus tumors and Pancoast's syndrome.

Authors:  S M Arcasoy; J R Jett
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

3.  Hemivertebrectomy for apical chest tumors: is the risk justified by the outcome?

Authors:  L Spaggiari; M Rusca; P Carbognani; P Solli
Journal:  Ann Thorac Surg       Date:  1998-05       Impact factor: 4.330

Review 4.  Pancoast (superior sulcus) tumors.

Authors:  F C Detterbeck
Journal:  Ann Thorac Surg       Date:  1997-06       Impact factor: 4.330

5.  Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).

Authors:  V W Rusch; D J Giroux; M J Kraut; J Crowley; M Hazuka; D Johnson; M Goldberg; F Detterbeck; F Shepherd; R Burkes; T Winton; C Deschamps; R Livingston; D Gandara
Journal:  J Thorac Cardiovasc Surg       Date:  2001-03       Impact factor: 5.209

6.  A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

Authors:  J D Cox; N Azarnia; R W Byhardt; K H Shin; B Emami; T F Pajak
Journal:  J Clin Oncol       Date:  1990-09       Impact factor: 44.544

7.  Combined treatment in superior sulcus tumors.

Authors:  R Martínez-Monge; J Herreros; J J Aristu; J M Aramendía; I Azinovic
Journal:  Am J Clin Oncol       Date:  1994-08       Impact factor: 2.339

8.  Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet.

Authors:  P G Dartevelle; A R Chapelier; P Macchiarini; B Lenot; J Cerrina; F L Ladurie; F J Parquin; D Lafont
Journal:  J Thorac Cardiovasc Surg       Date:  1993-06       Impact factor: 5.209

9.  Influence of surgical resection and brachytherapy in the management of superior sulcus tumor.

Authors:  R J Ginsberg; N Martini; M Zaman; J G Armstrong; M S Bains; M E Burt; P M McCormack; V W Rusch; L B Harrison
Journal:  Ann Thorac Surg       Date:  1994-06       Impact factor: 4.330

10.  Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

Authors:  K S Albain; V W Rusch; J J Crowley; T W Rice; A T Turrisi; J K Weick; V A Lonchyna; C A Presant; R J McKenna; D R Gandara
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

View more
  1 in total

Review 1.  Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment.

Authors:  Christophoros N Foroulis; Paul Zarogoulidis; Kaid Darwiche; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Ilias Karapantzos; Kosmas Tsakiridis; Haidong Huang; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.